Atrial fibrillation in acute coronary syndrome: patient characteristics and appropriate utilisation of anti-thrombotic therapy in New Zealand (ANZACS-QI 39).
CONCLUSION: In New Zealand, one in seven patients presenting with ACS have AF, a third being new-onset AF. Antithrombotic management is inconsistent, with underutilisation of anticoagulants, particularly the DAT regimen, and is inadequately informed by stroke and bleeding risk scores.
PMID: 32777794 [PubMed - in process]
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research
More News: Angiography | Angioplasty | Atrial Fibrillation | Bleeding | Cardiology | Coronary Angioplasty | General Medicine | Heart | Heart Failure | New Zealand Health | Percutaneous Coronary Intervention | Stroke